US Patent Issued to Dana-Farber Cancer Institute on Oct. 21 for "T cell receptors specific to b-cell maturation antigen for treatment of cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,429, issued on Oct. 21, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"T cell receptors specific to b-cell maturation antigen for treatment of cancer" was invented by Jooeun Bae (West Roxbury, Mass.), Nikhil C. Munshi (Needham, Mass.) and Kenneth C. Anderson (Wellesley, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to T cell receptors (e.g., T cell receptors comprising alpha chains and beta chains) specific to B-cell maturation antigen (BCMA), T cells comprising same, and methods of use thereof."

The patent was filed on March 5, 2020, under Application No. 17/430,938.

*For further information, including...